- Moderna Inc (NASDAQ: NASDAQ:MRNA) appointed James Mock as its Chief Financial Officer, beginning September 6, 2022.
- In May, Moderna's newly appointed Chief Financial Officer, Jorge Gomez, departed the company immediately after joining office a day before.
- The announcement follows the public disclosure by Gomez's former employer, Dentsply Sirona Inc (NASDAQ: XRAY), of an ongoing internal investigation into some issues, including financial reporting.
- Related Content: Moderna Justifies It Did Not Know About Investigation On Its New CFO.
- Following the appointment of Mr. Mock, David Meline will retire as the company's CFO effective the same date but will remain a consultant to the company to assist with the transition.
- Before joining Moderna, Mr. Mock served as Senior Vice President and CFO of PerkinElmer Inc (NYSE: NYSE:PKI).
- Price Action: MRNA shares are down 5.26% at $159.13 during the market session on the last check Wednesday.
- Photo via Wikimedia Commons
Read at Benzinga